Publications by authors named "Trever G Bivona"

97 Publications

Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts.

Science 2021 Jan 21. Epub 2021 Jan 21.

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.

View Article and Find Full Text PDF
January 2021

Allosteric SHP2 inhibitors in cancer: Targeting the intersection of RAS, resistance, and the immune microenvironment.

Curr Opin Chem Biol 2021 Jan 6;62:1-12. Epub 2021 Jan 6.

Department of Medicine, University of California, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA. Electronic address:

View Article and Find Full Text PDF
January 2021

Long non-coding RNA ESCCAL-1 promotes esophageal squamous cell carcinoma by down regulating the negative regulator of APOBEC3G.

Cancer Lett 2020 Nov 6;493:217-227. Epub 2020 Sep 6.

Translational Medical Center, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, 450007, PR China. Electronic address:

View Article and Find Full Text PDF
November 2020

Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing.

Cell 2020 Sep 20;182(5):1232-1251.e22. Epub 2020 Aug 20.

Department of Medicine, University of California, San Francisco, San Francisco, CA 94158, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA. Electronic address:

View Article and Find Full Text PDF
September 2020

EGFR targeted therapy resistance: current status, challenges, and future outlook.

Authors:
Trever G Bivona

J Thorac Dis 2020 May;12(5):2849-2850

Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.

View Article and Find Full Text PDF
May 2020

Overcoming the challenges of cancer drug resistance through bacterial-mediated therapy.

Chronic Dis Transl Med 2019 Dec 8;5(4):258-266. Epub 2020 Jan 8.

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143, USA.

View Article and Find Full Text PDF
December 2019

Betacellulin drives therapy resistance in glioblastoma.

Neuro Oncol 2020 04;22(4):457-469

Department of Neurology, University of California San Francisco (UCSF), San Francisco, California.

View Article and Find Full Text PDF
April 2020

Synthetic Essentiality of Metabolic Regulator PDHK1 in PTEN-Deficient Cells and Cancers.

Cell Rep 2019 08;28(9):2317-2330.e8

Department of Medicine, University of California, San Francisco, San Francisco, CA 94158, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; QB3, California Institute for Quantitative Biosciences, San Francisco, CA 94158, USA. Electronic address:

View Article and Find Full Text PDF
August 2019

Targeting Oncogenic BRAF: Past, Present, and Future.

Cancers (Basel) 2019 Aug 16;11(8). Epub 2019 Aug 16.

Department of Medicine, University of California, San Francisco, CA 94143, USA.

View Article and Find Full Text PDF
August 2019

Engineering Multidimensional Evolutionary Forces to Combat Cancer.

Cancer Discov 2019 05 16;9(5):587-604. Epub 2019 Apr 16.

Department of Medicine, University of California, San Francisco, California.

View Article and Find Full Text PDF
May 2019

Dampening oncogenic RAS signaling.

Authors:
Trever G Bivona

Science 2019 03;363(6433):1280-1281

Department of Medicine, Cellular and Molecular Pharmacology, and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158, USA.

View Article and Find Full Text PDF
March 2019

Polytherapy and Targeted Cancer Drug Resistance.

Trends Cancer 2019 03 26;5(3):170-182. Epub 2019 Feb 26.

Department of Medicine, University of California, San Francisco, 600 16(th) Street, Box 2140, Genentech Hall, San Francisco, CA 94158, USA; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, 600 16(th) Street, Box 2140, Genentech Hall, San Francisco, CA 94158, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 600 16(th) Street, Box 2140, Genentech Hall, San Francisco, CA 94158, USA. Electronic address:

View Article and Find Full Text PDF
March 2019

Emerging Targeted Therapies for the Treatment of Non-small Cell Lung Cancer.

Curr Oncol Rep 2019 02 26;21(3):21. Epub 2019 Feb 26.

Department of Medicine, Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA, USA.

View Article and Find Full Text PDF
February 2019

Principles of Resistance to Targeted Cancer Therapy: Lessons from Basic and Translational Cancer Biology.

Trends Mol Med 2019 03 24;25(3):185-197. Epub 2019 Jan 24.

Department of Medicine, University of California, San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. Electronic address:

View Article and Find Full Text PDF
March 2019

Circulating tumor DNA analysis in patients with EGFR mutant lung cancer.

J Thorac Dis 2018 Nov;10(Suppl 33):S4061-S4064

Department of Medicine, University of California, San Francisco, CA, USA.

View Article and Find Full Text PDF
November 2018

Immunohistochemistry to Study YAP in Human Tissue Samples.

Methods Mol Biol 2019 ;1893:89-95

Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.

View Article and Find Full Text PDF
June 2019

Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient With a MET Exon 14 Skipping Mutation.

Clin Lung Cancer 2019 03 20;20(2):e137-e141. Epub 2018 Nov 20.

Department of Medicine, University of California, San Francisco, San Francisco, CA; Hellen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA. Electronic address:

View Article and Find Full Text PDF
March 2019

Emerging application of genomics-guided therapeutics in personalized lung cancer treatment.

Ann Transl Med 2018 May;6(9):160

Department of Medicine, University of California, San Francisco, CA, USA.

View Article and Find Full Text PDF
May 2018